MEGHAN GALLI: Open Payments
NPI 1053945204 · GUILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 24 payments from 9 companies in 2025. Trend: 2023 $594 · 2024 $741 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $189 |
| COLOPLAST CORP | 7 | $132 |
| Sumitomo Pharma America, Inc. | 3 | $64 |
| ABBVIE INC. | 2 | $38 |
| PFIZER INC. | 1 | $31 |
| Calyxo, Inc. | 1 | $21 |
| Agiliti Surgical, Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Veozah, Luja Coude, ORGOVYX, BOTOX, XTANDI, CVAC ASPIRATION SYSTEM, GEMTESA, Boston Scientific Lumenis Pulse 120H Holmium Laser w/ MOSES Technology.
Industry payments across CT — which companies pay providers there.
